Search research articles
Contact Us
Filters
Showing results (201-210 of 215) with videos related to
Page
of 22
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 6, 2018
Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine
Ouldouz Ghashghaei, Samantha Caputo, Miquel Sintes, et al.
Molecules (Basel, Switzerland)
|
December 29, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2
Diego Muñoz-Torrero, Arduino A Mangoni, Hong Liu, et al.
Journal of Medicinal Chemistry
|
August 12, 2009
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds
Pelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Chemico-Biological Interactions
|
February 20, 2010
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates
Pelayo Camps, Xavier Formosa, Carles Galdeano, et al.
ACS Central Science
|
April 28, 2025
A Multicomponent Reaction-Based Platform Opens New Avenues in Aryl Hydrocarbon Receptor Modulation
Pau Nadal Rodríguez, Frederick Hartung, Marina Pedrola, et al.
Journal of Medicinal Chemistry
|
July 25, 2020
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
F Javier Pérez-Areales, María Garrido, Ester Aso, et al.
Chemmedchem
|
September 23, 2010
Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates
Elisabet Viayna, Tània Gómez, Carles Galdeano, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases
Carles Galdeano, Elisabet Viayna, Irene Sola, et al.
European Journal of Medicinal Chemistry
|
August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I<sub>2</sub> Receptor Ligands for Alzheimer's Disease
Sònia Abás, Sergio Rodríguez-Arévalo, Andrea Bagán, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 215) with videos related to
Sort By:
Page
of 22
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 6, 2018
Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine
Ouldouz Ghashghaei, Samantha Caputo, Miquel Sintes, et al.
Molecules (Basel, Switzerland)
|
December 29, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2
Diego Muñoz-Torrero, Arduino A Mangoni, Hong Liu, et al.
Journal of Medicinal Chemistry
|
August 12, 2009
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds
Pelayo Camps, Xavier Formosa, Carles Galdeano, et al.
Chemico-Biological Interactions
|
February 20, 2010
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates
Pelayo Camps, Xavier Formosa, Carles Galdeano, et al.
ACS Central Science
|
April 28, 2025
A Multicomponent Reaction-Based Platform Opens New Avenues in Aryl Hydrocarbon Receptor Modulation
Pau Nadal Rodríguez, Frederick Hartung, Marina Pedrola, et al.
Journal of Medicinal Chemistry
|
July 25, 2020
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
F Javier Pérez-Areales, María Garrido, Ester Aso, et al.
Chemmedchem
|
September 23, 2010
Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates
Elisabet Viayna, Tània Gómez, Carles Galdeano, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases
Carles Galdeano, Elisabet Viayna, Irene Sola, et al.
European Journal of Medicinal Chemistry
|
August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I<sub>2</sub> Receptor Ligands for Alzheimer's Disease
Sònia Abás, Sergio Rodríguez-Arévalo, Andrea Bagán, et al.
Page
of 22